Searched for
GLENMARK CLINICAL TRIAL
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- Glenmark initiates multi-nation Phase 3 clinical trial for lung cancer drugGlenmark Pharmaceuticals has commenced a Phase 3 clinical trial across multiple countries, including India, Russia, Brazil, and Mexico, for...
- Glenmark receives DCGI nod to conduct clinical trials of its molecule on cancer patientsThe Mumbai-based drug major said, GRC 54276 has shown tumor cell killing ability in preclinical studies as a single agent and as well in co...
- No 'significant' benefit of favipiravir, umifenovir combination in Covid treatment: GlenmarkGlenmark had in May intimated the study to examine whether early administration of a combination of Favipiravir and Umifenovir enhances ant...
- Favirpiravir yet to find favour with ICMRHowever, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET ...
- Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patientsThe Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipi...
- Glenmark pharma starts clinical trial on antiviral Favipiravir for Covid-19 treatmentThe drug sold under brand name Avigan by Fujifilm Toyama Chemical has demonstrated activity against influenza viruses and has been approved...
- Clinical trials by pharmaceutical companies still gasping for transparencyData available in the public domain shows Malpani Hospital has conducted over 40 clinical trials for osteoarthritis and rheumatoid arthriti...
- CDSCO issues show cause notice to Glenmark over clinical trial in JaipurThe apex drug regulatory body has sent show cause notices to Glenmark as well as the investigator in charge of the trial at the hospital, s...
- Glenmark clinical trial in Jaipur dragged into controversy, CDSCO to probe allegationsThe issue has escalated to a point where even the Central Drugs Standard Control Organisation, India's apex drug regulatory body, has sent ...
- Glenmark's novel antibody GBR 1302 to enter clinical trialsGlenmark has completed the pre-clinical evaluation for its bi-specific antibody GBR 1302 and filed the phase I trial application for the sa...
- Glenmark Pharmaceuticals' new molecule enters human trialsGlenmark Pharmaceuticals S.A., a wholly owned Swiss subsidiary of Glenmark Pharmaceuticals, said GBR 830 is entering human trials.
- Glenmark Pharmaceuticals's monoclonal antibody for pain entering human trialsGBR 900 is a monoclonal antibody for the treatment of chronic pain targeting TrkA, the receptor of nerve growth factor (NGF).
- Glenmark enters phase II clinical trial for new drug moleculeGlenmark Pharmaceuticals said it has entered the phase II clinical trials for its new drug molecule aimed at treating ulcerative colitis.
- Glenmark starts Phase-IIb human trials of Revamilast moleculeGlenmark Pharmaceuticals on Wednesday said it has started Phase-IIb human trials of its 'Revamilast' molecule.
- Glenmark seeks action against govt hospital for falsifying dataGlenmark Pharmaceuticals has complained to the drug regulator that the government-funded research centre, Guru Govind Singh Hospital in Jam...
- Glenmark Pharma looks to out-license two molecules this yearGlenmark Pharmaceuticals on Friday said it would look at out-licensing two of its molecules this year that are in clinical trials.
- Glenmark to start phase I clinical trials of GBR 500 in USDrug firm Glenmark pharmaceuticals on Friday said it will file an application with American health regulator US Food and Drug Administrator...
- Glenmark soars on likely deal of $150 mnMarket participants expect payout to Glenmark from such a deal would include upfront and milestone payments and royalties on sales.
- Glenmark's asthma molecule trials crawl onGlenmark Pharmaceuticals’ much-hyped asthma research molecule Oglemilast (code name GRRC 3886), is witnessing slower clinical progress, put...
Load More
